Skip to content

Anti-RBD Single-Chain Variable Fragments Library (scFv Library) Generation toward the Development of a Diagnostic Platform for SARS-CoV-2.

Jul 2026 · ACS Infectious Diseases · 0 citations · 47 references
Medicine

TL;DR

A mouse-derived single-chain variable fragment phage display library is generated against the RBD of the SARS-CoV-2 spike protein to highlight the potential utility of these scFvs as candidate reagents for the development of improved diagnostic platforms and as scaffolds for next-generation monoclonal antibody-based therapeutics.

Abstract

The continued emergence of SARS-CoV-2 variants worldwide underscores the need for effective measures to combat the current and future outbreaks. The receptor-binding domain (RBD) of the spike glycoprotein plays a critical role in viral entry and represents a highly immunogenic target. In this study, we generated a mouse-derived single-chain variable fragment (scFv) phage display library against the RBD of the SARS-CoV-2 spike protein. Peptide ELISA-based epitope mapping demonstrated that selected monoclonal scFv phages exhibited broad epitope recognition and reactivity across multiple recently reported variants. In a SARS-CoV-2 pseudovirus neutralization assay, scFv C4 showed potent neutralizing activity against the wild-type, Gamma, and Delta variants, with IC50 values below 4 μg/mL. These findings highlight the potential utility of these scFvs as candidate reagents for the development of improved diagnostic platforms and as scaffolds for next-generation monoclonal antibody-based therapeutics.

View source

Similar papers

Open access Aug 2026

Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody

Comparing wild-type XG83 and modified MuXG83 shows how allosteric tuning affects antibody-antigen compatibility in developing variations like Omicron, and indicates that non-epitope (potentially allosteric) changes to CDRH3 are also important while investigating potential development and neutralization before advanceme...

Muhammad Waqas Nasir, Qi-Yun Liang, Jun He et al. · 0 citations
Open access Jul 2026

Structure-Based Adaptation of a SARS-CoV-2 Neutralizing Peptide to New Virus Variants.

The utility of the LW25.13 peptide as a scaffold that can be adapted to different virus variants, which may prove useful for the development of peptides against new coronavirus variants of concern in the future, is illustrated.

Nina Raasch, L. Weissenborn, Elie Richel et al. · 0 citations
Open access Aug 2026

Structural and mutational analyses define distinct molecular routes to broad SARS-CoV-2 receptor-binding domain recognition

Two human-derived monoclonal antibodies are characterized that recognize conserved epitopes on the SARS-CoV-2 RBD and retain activity across antigenically distinct variants, and conserved, mutationally constrained epitopes may serve as targets for vaccines designed to elicit antibody responses resilient to ongoing SARS...

M. Abernathy, William B. Foreman, Jasmyn A. Lopez et al. · 0 citations
Open access Aug 2026

An IgG-like fusion protein comprising an anti-Spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern

A bispecific fusion protein with potent broad-spectrum neutralizing activity against SARS-CoV-2 variants is developed and provides a promising strategy for next-generation coronavirus biologics.

Zhi-Zhong Wei, Ximing Liu, Kailun Wang et al. · 0 citations
Open access Jul 2026

Antibody evasion and receptor binding of SARS-CoV-2 variants PQ.16.1.1 and RK.1

Evaluations utilizing surface plasmon resonance and pseudovirus assays demonstrate that these sublineages exhibit significantly reduced human ACE2 receptor engagement compared to their parental strain, which suggests these variants will soon spread globally and emphasize the critical need for ongoing surveillance to mo...

Pei-Zhuo He, Yun-Wen Song, Cai-Wan Guo et al. · 0 citations
Open access Jul 2026

A Variant-Resistant Linear Epitope in the SARS-CoV-2 Nucleocapsid Protein for Antigen Detection

The results provide an epitope-level explanation for the sustained diagnostic reliability of the mAb N179-based assay against emerging variants, clarify the molecular basis for its lack of cross-reactivity, and may inform the rational design of SARS-CoV-2 diagnostics targeting conserved, mutation-resistant epitopes.

Zhoujun Su, Junhao Guo, He-Feng Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.